Next Article in Journal
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
Next Article in Special Issue
Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes
Previous Article in Journal
Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors
Previous Article in Special Issue
Simple and Robust Detection of CYP2D6 Gene Deletions and Duplications Using CYP2D8P as Reference
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(2), 252; https://doi.org/10.3390/ph15020252
Action Date Notes Link
article xml file uploaded 19 February 2022 11:04 CET Original file -
article xml uploaded. 19 February 2022 11:04 CET Update https://www.mdpi.com/1424-8247/15/2/252/xml
article pdf uploaded. 19 February 2022 11:04 CET Version of Record https://www.mdpi.com/1424-8247/15/2/252/pdf
article html file updated 19 February 2022 11:06 CET Original file -
article html file updated 31 July 2022 23:56 CEST Update https://www.mdpi.com/1424-8247/15/2/252/html
Back to TopTop